Company description:
Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.
Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patients cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).
Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.
Job description:
Join Us in Changing Lives
AtOXB, our people are at the heart of everything we do. Were on a mission to enable life-changing therapies to reach patients around the worldand were looking for passionate individuals who embody our core values every day:Responsible, Responsive, Resilient, and Respectful.
We are currently recruiting for a Process Engineer to join the Manufacturing Sciences and Technology (MSAT) team. The purpose of this role is to plan, execute and report completion of MSAT-related projects or tasks in alignment with department objectives.
Your responsibilities in this role would be:
* The delivery of assigned technical projects/tasks working directly with your Manager to ensure project time-lines are met according to internal and/or customer needs
* Trouble shooting, identification and problem solving in the plant for process and quality issues of existing processes
* Supporting the implementation of new processes/products into OXB facilities and third party CMOs
* Supports improvement projects to achieve increased productivity improvement, quality and reliability improvements
* Analyses batch records and quality results and monitors consistency of operations by using appropriate database and statistical tools; propose and implement corrective and improvement actions
* Work will be conducted in compliance with OXBs Quality, Safety and Environmental systems and procedures
We are Looking For:
* Degree or equivalent experience in Chemical or Biochemical Engineering with an appropriate level of relevant experience.
* Expertise in bioprocess design, scale-up and commercialisation
* Knowledge of GMP manufacturing and including quality and regulatory requirements
* Knowledge and relevant experience in the scale up and industrialisation of GMP manufacturing bioprocesses
* Understanding of quality management systems, environmental, health and safety aspects of the work and regulatory requirements
* Experience of using statistical data analysis tools
* Understanding of process hazard analysis (PHA) methodologies such as FMEA, HAZOP and HACCP would be desirable
About Us:
OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.
OXB collaborates with some of the worlds most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXBs world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise.
Why Join Us?
* ??Competitive total reward packages
* ??Wellbeing programmesthat support your mental and physical health
* ??Career development opportunitiesto help you grow and thrive
* ??Supportive, inclusive, and collaborative culture
* ??State-of-the-art labs and manufacturing facilities
* ?? A company that lives its values:Responsible, Responsive, Resilient, Respect
We want you to feel inspired every day. At OXB, were future-focused and growing fast. We succeed togetherthrough passion, commitment, and teamwork.
Ready to Make a Difference?
Collaborate. Contribute. Change lives.
We offer:
Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.
Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patients cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).
Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.
JBRP1_UKTJ